Tipelukast

C29H38O7S

Tipelukast, 125961-82-2, KCA 757, KCA-757, MN-001, MN-001 (Tipelukast), KCA757, KCA 757;MN 001, Tipelukast (USAN), TIPELUKAST [USAN], 08379P260O, 4-(6-Acetyl-3-(3-((4-acetyl-3-hydroxy-2-propylphenyl)thio)propoxy)-2-propylphenoxy)butanoic acid, Butanoic acid, 4-[6-acetyl-3-[3-[(4-acetyl-3-hydroxy-2-propylphenyl)thio]propoxy]-2-propylphenoxy]-, Tipelukast [USAN:INN], MN 001 (pharmaceutical), UNII-08379P260O, 4-(6-Acetyl-3-(3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy)-2-propylphenoxy)butyric acid, 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid, Butanoic acid, 4-(6-acetyl-3-(3-((4-acetyl-3-hydroxy-2-propylphenyl)thio)propoxy)-2-propylphenoxy)-, MN 001, TIPELUKAST [INN], TIPELUKAST [MART.], TIPELUKAST [WHO-DD], 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenyl)sulfanylpropoxy]-2-propylphenoxy]butanoic acid, SCHEMBL154898, CHEMBL2104988, DTXSID00925325, CHEBI:177735, BCP17000, AKOS015914770, CS-6822, DB12435, SB17439, HY-14938, MS-29819, D06659, L001366, Q27236352, KCA-757; MN-001; KCA757; MN001; KCA 757; MN 001, 4-(6-Acetyl-3-{3-[(4-acetyl-3-hydroxy-2-propylphenyl)sulfanyl]propoxy}-2-propylphenoxy)butanoic acid, 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propyl-phenylthio)propoxy]-2-propylphenoxy]butyric acid, 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenyl)sulanylpropoxy]-2-propylphenoxy]butanoic acid

Tipelukast is  classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate